Jan M. Van Laar

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitis.

Human TBK1 deficiency: An expanded spectrum from autoinflammation to viral encephalitis.

Journal: Journal of human immunity
Published: November 17, 2025

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

NTRK1-rearranged histiocytosis: clinicopathologic and molecular features.

Journal: Blood advances
Published: February 10, 2025

Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol.

Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol.

Journal: BMJ open
Published: February 06, 2025

Unexpected finding of encapsulating peritoneal sclerosis: mind the cocoon.

Unexpected finding of encapsulating peritoneal sclerosis: mind the cocoon.

Journal: BMJ case reports
Published: January 27, 2025

The relationship between immunoglobulin G4-related disease and malignancy.

The relationship between immunoglobulin G4-related disease and malignancy.

Journal: Reumatologia
Published: January 06, 2025

Chemotherapy or Immunotherapy in Behçet's Disease?

Chemotherapy or Immunotherapy in Behçet's Disease?

Journal: NEJM evidence
Published: October 22, 2024

Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms.

Driver mutations in myeloid and lymphoid cells point to multipotent progenitor origin of diverse histiocytic neoplasms.

Journal: Blood neoplasia
Published: September 03, 2024

Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.

Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis.

Journal: Blood advances
Published: May 20, 2024

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue.

Recurrent CLTC::SYK fusions and CSF1R mutations in juvenile xanthogranuloma of soft tissue.

Journal: Blood
Published: May 14, 2024

Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.

Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium.

Journal: Blood neoplasia
Published: April 11, 2024

A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis.

A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis.

Journal: Communications biology
Published: April 06, 2024

Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?

Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?

Journal: Heliyon
Published: March 26, 2024
Showing 1-12 of 83

Last Updated: 09/26/2026